{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":5,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":5,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"6f2a9cc7c515","filters":{"venue":"European Oncology & Haematology"}},"results":[{"id":"W2776607461","doi":"10.17925/eoh.2017.13.02.147","title":"Bmi1 – A Path to Targeting Cancer Stem Cells","year":2017,"lang":"en","type":"article","venue":"European Oncology & Haematology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"BMI1; PRC2; Hox gene; Cancer research; Cancer stem cell; Polycomb-group proteins; Homeotic gene; Stem cell; Radioresistance; Repressor; Biology; Cancer; EZH2; Cell biology; Genetics; Gene; Histone; Transcription factor; Cell culture","authors":[{"name":"David Bakhshinyan","is_ca":true},{"name":"Ashley Adile","is_ca":true},{"name":"Chitra Venugopal","is_ca":true},{"name":"Sheila K. Singh","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02527399511552401,"gpt":0.3208564190321812,"spread":0.2955824239166571,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003329987,0.0002648995,0.0002603658,0.0003140724,0.0001800802,0.0005682118,0.0004374128,0.0005234109,0.003066334],"category_scores_gemma":[0.0002980175,0.0001707335,0.0001852097,0.0001644245,0.0004490463,0.0005575601,0.000468806,0.002600869,0.001274386],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004770322,"about_ca_system_score_gemma":0.0004180119,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003545928,"about_ca_topic_score_gemma":0.0009546657,"domain_scores_codex":[0.9998877,0.0000201222,0.000004917316,0.0000199245,0.00004640022,0.00002095266],"domain_scores_gemma":[0.9999053,0.00001602152,0.00001655504,0.00000870067,0.00002385875,0.00002949466],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008100776,0.000272406,0.000940108,0.00170113,0.0001244475,0.0003485837,0.0002258361,0.001123346,0.4452733,0.08833054,0.05468591,0.4061645],"study_design_scores_gemma":[0.0001620211,0.0007853558,0.001394829,0.000175722,0.00004704735,0.0006911955,0.00004779772,0.0006988344,0.1070756,0.0138815,0.8750111,0.00002902553],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.1076413,0.6555872,0.07296883,0.08267608,0.007526676,0.0004380957,0.001933828,0.001776599,0.06945138],"genre_scores_gemma":[0.4507473,0.411406,0.0332539,0.02133728,0.002688103,0.0004360958,0.001931079,0.0002019426,0.07799825],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.003066334,"threshold_uncertainty_score":0.0102579,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W168572226","doi":"10.17925/eoh.2012.08.3.148","title":"Weighing Bone-targeted Treatment Options for Patients with Solid Tumours and Skeletal Complications from Metastatic Disease","year":2012,"lang":"en","type":"article","venue":"European Oncology & Haematology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Quality of life (healthcare); Disease; Clinical trial; Intensive care medicine; Oncology; Physical therapy; Internal medicine; Nursing","authors":[{"name":"Lesley Fallowfield","is_ca":false},{"name":"Roger von Moos","is_ca":false},{"name":"Luís Costa","is_ca":false},{"name":"Alison Stopeck","is_ca":false},{"name":"Mark Clemons","is_ca":true},{"name":"Noel W. Clarke","is_ca":false},{"name":"Ada Braun","is_ca":false},{"name":"Karen Chung","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02884813505321457,"gpt":0.3180163214109421,"spread":0.2891681863577275,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001381182,0.0002269034,0.0006091601,0.0005352824,0.000378135,0.0008164452,0.0002706306,0.0007931628,0.004717505],"category_scores_gemma":[0.005632006,0.00008853673,0.0004988028,0.0004652876,0.0002981463,0.001155054,0.0006041497,0.0009545183,0.0004396126],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004990984,"about_ca_system_score_gemma":0.0007393718,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005025693,"about_ca_topic_score_gemma":0.002139963,"domain_scores_codex":[0.9990634,0.0004267604,0.0001073682,0.00003603569,0.0003171699,0.00004922007],"domain_scores_gemma":[0.998931,0.0005512526,0.0002239942,0.00002094056,0.0001107965,0.0001620466],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001891396,0.0004381858,0.01335885,0.002493115,0.0004488976,0.0005186695,0.0003349833,0.001324645,0.002012762,0.00443872,0.016645,0.9560947],"study_design_scores_gemma":[0.004645249,0.02178236,0.1690678,0.01563366,0.00449357,0.01184612,0.006213962,0.005337863,0.005714616,0.05897754,0.6960217,0.0002654246],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2044097,0.6095504,0.003717724,0.1354165,0.002337318,0.0003414703,0.0004473069,0.00005872126,0.0437209],"genre_scores_gemma":[0.7289612,0.2393615,0.009825005,0.01295437,0.00394942,0.0002710455,0.0002552974,0.00002183199,0.004400399],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004717505,"threshold_uncertainty_score":0.01578158,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2499395398","doi":"10.17925/eoh.2007.0.2.32","title":"Treatment of Multiple Myeloma Patients Who Have Received at Least One Prior Therapy","year":2007,"lang":"en","type":"article","venue":"European Oncology & Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Multiple myeloma; Internal medicine","authors":[{"name":"Jean‐Luc Harousseau","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05431918023108535,"gpt":0.3364749727521673,"spread":0.2821557925210819,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001632361,0.000212372,0.0007428355,0.0001983682,0.0007136858,0.0002847627,0.000235232,0.0005192002,0.008122549],"category_scores_gemma":[0.0004208506,0.00007532754,0.0004729854,0.0003195105,0.000131035,0.0002277502,0.000288041,0.0006325594,0.002232251],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00017983,"about_ca_system_score_gemma":0.000381549,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005127196,"about_ca_topic_score_gemma":0.001298842,"domain_scores_codex":[0.999887,0.00002370025,0.00001085236,0.00001634005,0.00002864428,0.00003354248],"domain_scores_gemma":[0.9998631,0.0000156332,0.00002052524,0.000008165325,0.0000213702,0.00007116984],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.009157715,0.005302432,0.1452699,0.002069488,0.0004758585,0.0139211,0.0006451727,0.0005159334,0.03621805,0.001321083,0.1089051,0.6761982],"study_design_scores_gemma":[0.003810784,0.01551515,0.3406968,0.0009204183,0.0007797079,0.04493975,0.0004861669,0.001161998,0.009845708,0.001811541,0.5799525,0.00007945864],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7682382,0.09098987,0.00365375,0.01534374,0.002447106,0.001549313,0.002417546,0.0004057752,0.1149548],"genre_scores_gemma":[0.9106478,0.03569771,0.004753024,0.01019791,0.001865673,0.0008322037,0.003180988,0.00003603947,0.03278862],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008122549,"threshold_uncertainty_score":0.02717268,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2559226961","doi":"10.17925/eoh.2016.12.02.79","title":"Treatment Update for Women with Hormone Receptor-positive Advanced Breast Cancer","year":2016,"lang":"en","type":"article","venue":"European Oncology & Haematology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"AstraZeneca","keywords":"Anastrozole; Medicine; Fulvestrant; Breast cancer; Oncology; Internal medicine; Hormone receptor; Cancer; Hormonal therapy; Hormone therapy; Hormone; Gynecology; Tamoxifen","authors":[{"name":"Karen A. Gelmon","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.004953099816584024,"gpt":0.2498291850781909,"spread":0.2448760852616069,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001374605,0.0004227875,0.0008810234,0.0009993165,0.0004248607,0.001032428,0.000721436,0.002386965,0.008392286],"category_scores_gemma":[0.004096049,0.0002253605,0.000623898,0.001149845,0.0002121544,0.001130442,0.0004857465,0.002976129,0.003496487],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000811927,"about_ca_system_score_gemma":0.001366374,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001940806,"about_ca_topic_score_gemma":0.007255788,"domain_scores_codex":[0.9993766,0.0002088857,0.0001149003,0.00003395715,0.0002222154,0.00004357416],"domain_scores_gemma":[0.9975947,0.0008763653,0.0003504081,0.00004863742,0.0008759968,0.0002538323],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002929178,0.0001082246,0.0008631091,0.002190168,0.00005952704,0.0003410827,0.00004926172,0.0001515118,0.0006387321,0.001125803,0.3775047,0.6166749],"study_design_scores_gemma":[0.00005863157,0.0001259811,0.001783872,0.001074916,0.00009055023,0.0007766385,0.00003994134,0.00007472278,0.0001128165,0.0004006368,0.9954526,0.000008637409],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003988598,0.747582,0.00237343,0.1670282,0.0242062,0.0001880663,0.001807719,0.0004761589,0.05234968],"genre_scores_gemma":[0.02739728,0.7910081,0.01185487,0.09517065,0.02742115,0.000495406,0.004583219,0.0001064306,0.04196285],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008392286,"threshold_uncertainty_score":0.02807498,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2380744455","doi":"10.17925/ohr.2015.11.01.57","title":"Gastrointestinal Stromal Tumors (GIST)—Paving the Way for Modern Oncology—Epidemiology, Diagnosis, Treatment","year":2015,"lang":"en","type":"article","venue":"European Oncology & Haematology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; GiST; Regorafenib; Imatinib; Sunitinib; Oncology; Internal medicine; Stromal tumor; Imatinib mesylate; Surgery; Radiology; Stromal cell; Colorectal cancer; Cancer","authors":[{"name":"Elena Tsvetkova","is_ca":true},{"name":"Esmeralda Celia Marginean","is_ca":true},{"name":"Carolyn Nessim","is_ca":true},{"name":"Shailendra Verma","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1902767056561658,"gpt":0.4133603984202704,"spread":0.2230836927641047,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010133,0.0002624632,0.0005013018,0.001518155,0.000362671,0.001365538,0.0003616469,0.0009002824,0.002382166],"category_scores_gemma":[0.001892635,0.0001504064,0.000191502,0.001968175,0.0009330845,0.00267029,0.0007122603,0.001705248,0.0006767532],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001027568,"about_ca_system_score_gemma":0.00155123,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00162125,"about_ca_topic_score_gemma":0.001625824,"domain_scores_codex":[0.9995934,0.0001429455,0.00006698866,0.00005483496,0.0001062794,0.00003549783],"domain_scores_gemma":[0.9988419,0.0002993816,0.0003056691,0.00005451499,0.0002893474,0.0002091484],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001562702,0.0001336508,0.04266773,0.00140788,0.00005863056,0.001127698,0.0001426849,0.0004519277,0.001788868,0.01557427,0.04698475,0.8895056],"study_design_scores_gemma":[0.00005548751,0.0004936209,0.09642013,0.00402753,0.0001426709,0.03013802,0.001587734,0.001462645,0.001192372,0.03272684,0.83164,0.0001130009],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0218753,0.8930031,0.003451844,0.06728752,0.002305155,0.00004466064,0.0003493645,0.0001068595,0.01157614],"genre_scores_gemma":[0.1308966,0.8451156,0.005354981,0.006975349,0.008760306,0.00003412065,0.0005268197,0.00002683113,0.002309334],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002382166,"threshold_uncertainty_score":0.007969141,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}